PT1047413E - Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a - Google Patents

Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a Download PDF

Info

Publication number
PT1047413E
PT1047413E PT99900531T PT99900531T PT1047413E PT 1047413 E PT1047413 E PT 1047413E PT 99900531 T PT99900531 T PT 99900531T PT 99900531 T PT99900531 T PT 99900531T PT 1047413 E PT1047413 E PT 1047413E
Authority
PT
Portugal
Prior art keywords
pharmaceutical composition
blood pressure
aminopeptidase
specific inhibitor
decreasing blood
Prior art date
Application number
PT99900531T
Other languages
English (en)
Inventor
Bernard Pierre Roques
Pierre Corvol
Marie-Claude Fournie-Zaluski
Catherine Llorens-Cortes
Original Assignee
Inst Nat Sante Rech Med
Centre Nat Rech Scient
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Inst Nat Sante Rech Med, Centre Nat Rech Scient filed Critical Inst Nat Sante Rech Med
Publication of PT1047413E publication Critical patent/PT1047413E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4151,2-Diazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
PT99900531T 1998-01-16 1999-01-14 Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a PT1047413E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9800453A FR2773712B1 (fr) 1998-01-16 1998-01-16 Composition pharmaceutique comprenant au moins un inhibiteur de l'aminopeptidase a

Publications (1)

Publication Number Publication Date
PT1047413E true PT1047413E (pt) 2011-10-13

Family

ID=9521866

Family Applications (1)

Application Number Title Priority Date Filing Date
PT99900531T PT1047413E (pt) 1998-01-16 1999-01-14 Composição farmacêutica incluindo pelo menos um inibidor da aminopeptidase a

Country Status (10)

Country Link
US (1) US6340708B1 (pt)
EP (1) EP1047413B1 (pt)
AT (1) ATE518533T1 (pt)
CA (1) CA2318348C (pt)
CY (1) CY1111905T1 (pt)
DK (1) DK1047413T3 (pt)
ES (1) ES2367568T3 (pt)
FR (1) FR2773712B1 (pt)
PT (1) PT1047413E (pt)
WO (1) WO1999036066A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2823212B1 (fr) * 2001-04-10 2005-12-02 Inst Nat Sante Rech Med Inhibiteurs de la toxine botulique de type b
US7235687B2 (en) 2002-07-16 2007-06-26 Institut National De La Sante Et De La Recherche Medicale (Inserm) Derivatives of 4,4′-dithiobis-(3-aminobutane-1-sulfphonates) and compositions containing same
FR2852597A1 (fr) * 2003-03-20 2004-09-24 Inst Nat Sante Rech Med Derives de 4,4'-dithiobis-(3-aminobutane-1-sulfonates) nouveaux et compositions les contenant
FR2931151A1 (fr) * 2008-05-13 2009-11-20 Pharmaleads Soc Par Actions Si Nouveaux derives d'amino-acides, leur procede de preparation et leur utilisation therapeutique
US10959938B2 (en) * 2011-12-21 2021-03-30 Quantum Genomics Combination of (3S,3S′) 4,4′-disulfanediylbis(3-aminobutane 1-sulfonic acid) and a second antihypertensive agent
WO2015086774A1 (en) 2013-12-11 2015-06-18 Attoquant Diagnostics Gmbh Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
EP2893925A1 (en) 2014-01-09 2015-07-15 Attoquant Diagnostics GmbH Compositions and methods for the treatment of diseases related to the renin-angiotensin-system
WO2018002673A1 (en) 2016-07-01 2018-01-04 N4 Pharma Uk Limited Novel formulations of angiotensin ii receptor antagonists
US20210309677A1 (en) 2018-10-26 2021-10-07 Quantum Genomics Novel aminophosphinic derivatives as aminopeptidase a inhibitors
TW202029962A (zh) 2018-10-26 2020-08-16 法商量子基因科技有限公司 胺肽酶a抑制劑及包含其的醫藥組合物
TW202100146A (zh) 2019-03-11 2021-01-01 法商量子基因科技有限公司 用於治療高血壓或心衰竭的化合物及包含其之組成物

Also Published As

Publication number Publication date
CA2318348A1 (fr) 1999-07-22
WO1999036066A1 (fr) 1999-07-22
FR2773712B1 (fr) 2000-06-02
US6340708B1 (en) 2002-01-22
CY1111905T1 (el) 2015-11-04
CA2318348C (fr) 2010-11-02
EP1047413A1 (fr) 2000-11-02
EP1047413B1 (fr) 2011-08-03
FR2773712A1 (fr) 1999-07-23
ES2367568T3 (es) 2011-11-04
ATE518533T1 (de) 2011-08-15
DK1047413T3 (da) 2011-10-31

Similar Documents

Publication Publication Date Title
CY1111905T1 (el) Φαρμακευτικη συνθεση περιλαμβανουσα εναν επιλεκτικο αναστολεα της αμινοπεπτιδασης α, ειδικα τον ec33, για τη μειωση της αρτηριακης πιεσεως
MY125150A (en) Factor vlla inhibitors
ATE469136T1 (de) Inhibitoren von 11-beta- hydroxysteroiddehydrogenase typ 1
ECSP034883A (es) Amidas de acidos antranilicos con cadena lateral de heteroarilsulfonilo, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que las contienen
NO20032488D0 (no) Orto-substituerte nitrogen-inneholdende bisarylforbindelser anvendt som kaliumkanalinhibitorer
SE0001899D0 (sv) New compounds
GB0105772D0 (en) Use
BR9814484A (pt) "pró-drogas de inibidores de aspartil protease"
BR0010562A (pt) Inibidor de metaloprotease do ácido hidrox mico de sulfona aromática
BR9811099A (pt) Inibidores de urocinase
BR9916004A (pt) Inibidores de proteinase c de pró-colágeno
WO2002032435A3 (en) A composition including a platelet activating factor inhibitor and an antioxidant which interferes with the arachidonic acid cascade
DK1765342T3 (da) Farmaceutisk sammensætning omfattende amlodipinbesilat og lisinoprildihydrat og fremgangsmåde til fremstilling deraf
HUP9801924A2 (hu) Nátrium/hidrogén-csere inhibitorokat és szív- és keringési zavarok kezelésére alkalmas hatóanyagokat tartalmazó gyógyszerkészítmény
BR0206819A (pt) Uso de inibidores de il-18 para o tratamento e/ou para a prevenção de doença cardìaca
BR0209155A (pt) Tablete farmacêutico tendo um teor de api elevado
ATE395057T1 (de) Gebrauchsfertige oxaliplatin-lösungen
AU2001285944A1 (en) Fungicidal agent containing n-chlorotaurine and use thereof
MXPA04005033A (es) Composicion farmaceutica que comprende una combinacion de metformina y acido 4-oxobutanoico y el uso de la misma para el tratamiento contra diabetes.
DK1622587T3 (da) Fast farmaceutisk præparat indeholdende levothyroxin- og/eller liothyroninsalte
DE60305018D1 (de) Citalopram zur behandlung von bluthochdruck
UY27475A1 (es) Amidas de ácido piperazinciclohexanocarboxílico sustituidas y su utilización
UA31078A (uk) Інгібітор вірусу імунодефіциту людини ( даримід )
UY26145A1 (es) Inhibidor de metaloproteasa acido aromatico sulfohidroxamico ley 17164 art 127